These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3123761)

  • 1. Trimethoprim-sulfamethoxazole in cyst fluid from autosomal dominant polycystic kidneys.
    Elzinga LW; Golper TA; Rashad AL; Carr ME; Bennett WM
    Kidney Int; 1987 Dec; 32(6):884-8. PubMed ID: 3123761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin activity in cyst fluid from polycystic kidneys.
    Elzinga LW; Golper TA; Rashad AL; Carr ME; Bennett WM
    Antimicrob Agents Chemother; 1988 Jun; 32(6):844-7. PubMed ID: 3415205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of trimethoprim and sulfamethoxazole into cysts in a patient with autosomal-dominant polycystic kidney disease.
    Schwab SJ; Weaver ME
    Am J Kidney Dis; 1986 May; 7(5):434-8. PubMed ID: 3518424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethoprim in the treatment and long-term control of urinary tract infection.
    Kasanen A; Toivanen P; Sourander L; Kaarsalo E; Aantaa S
    Scand J Infect Dis; 1974; 6(1):91-6. PubMed ID: 4208208
    [No Abstract]   [Full Text] [Related]  

  • 5. Five-year survey of changing patterns of susceptibility of bacterial uropathogens to trimethoprim-sulfamethoxazole and other antimicrobial agents.
    Alon U; Davidai G; Berant M; Merzbach D
    Antimicrob Agents Chemother; 1987 Jan; 31(1):126-8. PubMed ID: 3551824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease.
    Bennett WM; Elzinga L; Pulliam JP; Rashad AL; Barry JM
    Am J Kidney Dis; 1985 Dec; 6(6):400-4. PubMed ID: 4073019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful Treatment of Cyst Infection in an Infant With Autosomal Dominant Polycystic Kidney Disease Using Trimethoprim/Sulfamethoxazole.
    Yokoyama H; Sakaguchi M; Yamada Y; Kitamoto K; Okada S; Kanzaki S; Namba N
    Front Pediatr; 2020; 8():216. PubMed ID: 32582581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro demonstration of the efficacy of trimethoprim as an antibacterial agent in a comparative bacteriological study of the effects of trimethoprim, sulfamethoxazole and the combination trimethoprim-sulfamethoxazole.
    Küchler R; Koch UJ
    Chemotherapy; 1973; 18(4):242-52. PubMed ID: 4571975
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacodynamic evaluation of ofloxacin and trimethoprim-sulfamethoxazole in vaginal fluid of women treated for acute cystitis.
    Tartaglione TA; Johnson CR; Brust P; Opheim K; Hooton TM; Stamm WE
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1640-3. PubMed ID: 3075434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of trimethoprim against Borrelia burgdorferi.
    Reisinger EC; Wendelin I; Gasser R
    Eur J Clin Microbiol Infect Dis; 1997 Jun; 16(6):458-60. PubMed ID: 9248750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim, sulphamethoxazole, bacterial adhesion and polymorphonuclear leucocyte function.
    Emmanouilides CE; Lianou PE; Bassaris HP; Papavassiliou JT
    J Antimicrob Chemother; 1990 Dec; 26(6):803-12. PubMed ID: 2081720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial action of trimethoprim-sulfamethoxazole.
    Gallien R
    J Infect Dis; 1973 Nov; 128():Suppl:486-97 p. PubMed ID: 4202206
    [No Abstract]   [Full Text] [Related]  

  • 13. [Development of bacterial resistance against trimethoprim-sulfamethoxazole (Eusaprim)].
    Meyer-Rohn J; Liehr W
    Fortschr Med; 1974 Jan; 92(3):121-6. PubMed ID: 4206486
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of the antibacterial activity of sulphonamide-trimethoprim combinations.
    Fourie ED; van Straten AM; Maritz HC; van Rensburg AJ
    S Afr Med J; 1979 Mar; 55(14):544-7. PubMed ID: 377523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control of susceptibility tests with 5-micrograms trimethoprim disks.
    Barry AL; Jones RN; Gavan TL
    J Clin Microbiol; 1984 Oct; 20(4):817-9. PubMed ID: 6436317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole during hemodialysis.
    Nissenson AR; Wilson C; Holazo A
    Am J Nephrol; 1987; 7(4):270-4. PubMed ID: 3500644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci.
    Najjar A; Murray BE
    Antimicrob Agents Chemother; 1987 May; 31(5):808-10. PubMed ID: 3111362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibacterial activity of co-trimoxazole and tetroxoprim/sulfadiazine in vitro (author's transl)].
    Hahn H; Kirov A
    Arzneimittelforschung; 1980; 30(7):1047-8. PubMed ID: 7191284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of trimethoprim and sulfamethoxazole in the treatment of urinary tract infection.
    Crichton EP; McDonnell CE
    Can Med Assoc J; 1972 Aug; 107(4):292-5. PubMed ID: 4626767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethoprim/sulphamethoxazole resistance in Escherichia coli and Klebsiella spp. urinary isolates.
    Obaseiki-Ebor EE
    Afr J Med Med Sci; 1988 Sep; 17(3):175-9. PubMed ID: 2845759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.